Literature DB >> 17970057

Experimental models for therapeutic studies of transitional cell carcinoma.

Ute Gabriel1, Christian Bolenz, Maurice Stephan Michel.   

Abstract

Transitional cell carcinoma (TCC) is the second most common malignancy of the genito-urinary tract. To date, the therapy options available seem unable to prevent TCC recurrence and its progression, even though therapy studies are constantly investigating new treatment options. A great variety of TCC models have been described. For each study, the model has to be modified according to the specific investigative aim. The establishment of reproducible models is a continuing challenge. Currently, there is a strong tendency towards 3-dimensional models for in vitro studies. The aim of this article was to review current ex vivo and in vivo models used in studies of TCC therapy. We describe 2- and 3-dimensional cell and tissue cultures, as well as the set-up, investigative options and detection methods used in rodent heterotopic and orthotopic models.

Entities:  

Mesh:

Year:  2007        PMID: 17970057

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  11 in total

1.  Epidermal Growth Factor Receptor (EGFR)-targeted Photoimmunotherapy (PIT) for the Treatment of EGFR-expressing Bladder Cancer.

Authors:  Reema Railkar; L Spencer Krane; Q Quentin Li; Thomas Sanford; Mohammad Rashid Siddiqui; Diana Haines; Srinivas Vourganti; Sam J Brancato; Peter L Choyke; Hisataka Kobayashi; Piyush K Agarwal
Journal:  Mol Cancer Ther       Date:  2017-06-15       Impact factor: 6.261

2.  Latent Kaposi's sarcoma-associated herpesvirus infection in bladder cancer cells promotes drug resistance by reducing reactive oxygen species.

Authors:  Suhyuk Lee; Jaehyuk Jang; Hyungtaek Jeon; Jisu Lee; Seung-Min Yoo; Jinsung Park; Myung-Shin Lee
Journal:  J Microbiol       Date:  2016-10-29       Impact factor: 3.422

Review 3.  Exploring molecular genetics of bladder cancer: lessons learned from mouse models.

Authors:  Imran Ahmad; Owen J Sansom; Hing Y Leung
Journal:  Dis Model Mech       Date:  2012-03-15       Impact factor: 5.758

4.  Current animal models of bladder cancer: Awareness of translatability (Review).

Authors:  Jie Ding; Ding Xu; Chunwu Pan; Min Ye; Jian Kang; Qiang Bai; Jun Qi
Journal:  Exp Ther Med       Date:  2014-07-11       Impact factor: 2.447

Review 5.  Insights from animal models of bladder cancer: recent advances, challenges, and opportunities.

Authors:  Bincy Anu John; Neveen Said
Journal:  Oncotarget       Date:  2017-05-09

6.  Enhanced metastatic potential in the MB49 urothelial carcinoma model.

Authors:  Yu-Ru Liu; Peng-Nien Yin; Christopher R Silvers; Yi-Fen Lee
Journal:  Sci Rep       Date:  2019-05-15       Impact factor: 4.379

7.  Prognostic Significance of CREB-Binding Protein and CD81 Expression in Primary High Grade Non-Muscle Invasive Bladder Cancer: Identification of Novel Biomarkers for Bladder Cancer Using Antibody Microarray.

Authors:  Myung-Shin Lee; Joo Heon Kim; Ji-Su Lee; Seok Joong Yun; Wun-Jae Kim; Hanjong Ahn; Jinsung Park
Journal:  PLoS One       Date:  2015-04-27       Impact factor: 3.240

8.  IGF1R activation and the in vitro antiproliferative efficacy of IGF1R inhibitor are inversely correlated with IGFBP5 expression in bladder cancer.

Authors:  Yann Neuzillet; Elodie Chapeaublanc; Clémentine Krucker; Leanne De Koning; Thierry Lebret; François Radvanyi; Isabelle Bernard-Pierrot
Journal:  BMC Cancer       Date:  2017-09-07       Impact factor: 4.430

9.  The establishment of a growth-controllable orthotopic bladder cancer model through the down-regulation of c-myc expression.

Authors:  Ho Kyung Seo; Seung-Phil Shin; Na-Rae Jung; Whi-An Kwon; Kyung-Chae Jeong; Sang-Jin Lee
Journal:  Oncotarget       Date:  2016-07-22

Review 10.  Emerging Roles of Cancer Stem Cells in Bladder Cancer Progression, Tumorigenesis, and Resistance to Chemotherapy: A Potential Therapeutic Target for Bladder Cancer.

Authors:  Amira Abugomaa; Mohamed Elbadawy; Hideyuki Yamawaki; Tatsuya Usui; Kazuaki Sasaki
Journal:  Cells       Date:  2020-01-17       Impact factor: 6.600

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.